Received: 16 November 2020
Accepted: 12 May 2023
First Online: 5 June 2023
: This commentary does not utilize any data or perform any analysis and therefore not ethics approval was sought or obtained.
: No identifying information is included and therefore this is not applicable.
: RH receives funding for research from the Blue Cross Blue Shield of Michigan Foundation and the National Institute of Diabetes and Digestive and Kidney Diseases (5T32DK108740-05). ME receives funding from the Michigan Department of Health and Human Services and the National Institute on Drug Abuse (R01DA042859) and Blue Cross Blue Shield of Michigan.